To study the seeding propensity of CSF obtained from ALS patients and establish the translational potential to neutralize TDP-43 seeds with immunotherapy, the C-terminal region targeting TDP-43 monoclonal antibody (mAb), ACI-5891, was assessed. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.